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Abstract
Background: Identifying people at risk of developing diabetic foot complications is a vital step in prevention
programs in primary healthcare settings. Diabetic foot risk stratification systems predict foot ulceration. The aim of
this study was to explore the views and experiences of potential end users during development and formative
evaluations of an electronic diabetic foot risk stratification tool based on evidence-based guidelines and determine
the accuracy of the tool.
Methods: Formative evaluation of the risk tool occurred in five stages over an eight-month period and employed a
mixed methods research design consisting of semi-structured interviews, focus group and participant observation,
online survey, expert review, comparison to the Australian Guidelines and clinical testing.
Results: A total of 43 healthcare practitioners trialled the computerised clinical decision support system during
development, with multiple software changes made as a result of feedback. Individual and focus group participants
exposed critical design flaws. Live testing revealed risk stratification errors and functional limitations providing the
basis for practical improvements. In the final product, all risk calculations and recommendations made by the
clinical decision support system reflect current Australian Guidelines.
Conclusions: Development of the computerised clinical decision support system using evidence-based guidelines
can be optimised by a multidisciplinary iterative process of feedback, testing and software adaptation by experts in
modern development technologies.
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Background
Diabetes is now the leading cause of lower extremity
amputation in Australia [1], with approximately 85 % of
lower extremity amputations in people with diabetes
preceded by a diabetic foot ulcer [1–5]. The lifetime risk
of foot ulceration in people with diabetes is estimated to
be between 15 and 25 % [6–8]. Identifying people at risk
of foot complications is a crucial step in prevention.
Diabetic foot risk stratification predicts foot ulceration
and has accordingly become a cornerstone of man-
agement [9].
Diabetic foot risk stratification identifies clinical fea-
tures of individuals with diabetes that are predictive of
the relative risk of foot ulceration in the future. A large
number and type of clinical indicators including both
systemic and peripheral signs and symptoms have been
tested for their predictive value. Systemic features have
included age, sex, weight, height, body-mass index, dur-
ation of diabetes, type of diabetes, HbA1C, fasting
glucose, insulin regimes, history of myocardial infarct,
hypertension, erythrocyte sedimentation rate, serum
creatinine, kidney disease, eye disease, smoking and
alcohol intake [10]. Peripheral features have included
peripheral arterial disease, peripheral neuropathy, foot
deformity, prior foot ulceration or amputation, abnor-
mal plantar foot pressures, absent tendon reflexes,
ankle-brachial index, transcutaneous oxygen tension,
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lower extremity bypass, intermittent claudication, tinea
pedis, onychomycosis, lower leg oedema, dry or fissured
skin [10]. Social factors such as level of education, occupa-
tion, socioeconomic status, religion, ethnicity and marital
status have also been assessed [10–16].
Numerous diabetic foot risk classification systems are
described in the literature [7, 9, 17–25]. There is strong
evidence to justify risk stratification systems from large
cross-sectional and prospective studies [22, 26]. The risk
stratification systems have ranged from two to six risk clas-
sification groups. Monterio-Soares validated five inter-
national risk systems [7, 16, 19, 21, 22] and reported no
significant difference between them and all had a high ac-
curacy to detect people who would develop foot ulceration
[27]. Most recently the international collaboration, predic-
tion of diabetic foot ulcerations study (PODUS), of more
than 16,000 people with diabetes worldwide meta-analysis
reported, “the use of a 10-g monofilament or one absent
pedal pulse will identify those at moderate or intermediate
risk of foot ulceration, and a history of foot ulcers or
lower-extremity amputation is sufficient to identify those
at high risk” [28]. Notably foot deformity, ethnicity and eye
disease were not included in the analysis, as they were not
consistently defined in the included data sets.
As a result of expert input and review, in 2011
Australia’s National Health and Medical Research
Council (NHMRC) produced National Evidence-Based
Guideline on Prevention, Identification and Management
of Foot Complications in Diabetes (Guidelines) [24]. This
delivered a new national foot risk stratification sys-
tem, consisting of three levels; low, intermediate and
high risk of developing foot complications and the
Guideline recommended ‘any trained professional may
perform the risk assessment’ and urged the ‘urgent in-
tegration of decision support tools into medical soft-
ware’ [24]. Research has shown that although the
procedure for the assessment can be done by any
trained professional, the final assessment of level of
risk still proved problematic in the absence of add-
itional decision support [29].
Clinical decision support systems in medicine have
progressed from early systems that were never used in a
clinical setting to systems that are now integrated into
electronic health records across diverse clinical settings
[30, 31]. These have been known as artificial intelligence,
expert systems or clinical decision support systems
(CDSS). CDSS are defined as, “any electronic system de-
signed to aid directly in decision making, in which char-
acteristics of individual patients are used to generate
patient-specific assessments or recommendations that
are then presented to clinicians for consideration” [32].
They prompt clinicians through a protocol of pertinent,
evidence-based clinical actions and decisions to enhance
health-related decisions and actions. CDSS support
healthcare professionals to work at a higher level than
their standard scope of practice. This is required when
there is a workforce shortage of relevant expertise [33],
as occurs in Western Australia where a shortage of podi-
atrists in rural and remote areas is recognised [34, 35].
Successive systematic reviews have shown the beneficial
effect of CDSS on clinical decision making to improve
practitioner performance in diagnostic systems, re-
minder systems, chronic disease management pro-
cesses of care, drug dosing or prescribing systems,
improve rates of screening, and improve adherence to
recommended care standards [32, 36–41]. CDSS are
increasingly considered to be one of the most effect-
ive instruments to improve guideline implementation
[38, 42–44]. Trials of CDSS including diabetic foot
processes of care have all shown improvements in practi-
tioner performance, rates of screening and adherence to
guidelines [45–51]. Most recently, Moja’s systematic review
of new generation CDSS in electronic health records re-
ported no reduction in patient mortality but concluded that
they might moderately decrease morbidity [31]. Obstacles
to wider use of CDSS include poor usability or integration
into practitioner workflow, failure to integrate with primary
care information technology, the attitudes of end-users,
practitioner non-acceptance of computer recommenda-
tions, lack of clinician input into the development and their
failure to fulfil a perceived clinical need [38, 52, 53].
Diabetic foot risk stratification lends itself to CDSS be-
cause it has a strong evidence base, is unambiguous, has
explicit input and output criteria for each risk stratifica-
tion level, each foot risk choice is binary, every possible
permutation of foot risks can be decided by an algorithm
and produces a correct result. The Scottish Care Infor-
mation – Diabetes Collaboration system’s diabetic foot
electronic decision support tool is a CDSS and has been
validated and shown to be predictive of ulceration [22].
In this study we sought to act on the NHMRC Guide-
line to integrate CDSS into Australian electronic health
records to ensure it fitted within healthcare profes-
sionals’ usual workflow [24]. The underpinning ques-
tion related to whether the use of a CDSS could assist
non-podiatrists in risk stratification. The importance of
a usable and accurate foot risk assessment CDSS is
underpinned by the shortage of podiatrists in rural and
remote areas of Western Australia [34, 35].
This paper reports on the process of usability test-
ing that was conducted to develop and evaluate an
electronic diabetic foot risk stratification tool for its
use in the treatment and management of diabetes in
a largely Aboriginal population in Western Australia.
The aims of the usability testing were to not only
produce a system that was clinically correct, but one
that would fit within and enhance the workflow of
clinical practice of the health professionals concerned.
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Method
Risk tool design
A podiatrist at the Western Australian Centre for Rural
Health (DES) and software developers at the Centre for
Software Practice at The University of Western Australia
(led by DGG) collaborated to develop the risk tool. It
was designed to be used by both podiatrists and non-
podiatrists for assessing foot risk in people with diabetes
in the primary healthcare setting. A usability design
process was used incorporating an early focus on users,
integrated design, early and continual user testing and it-
erative design [54]. The term ‘usability’ means getting
‘real’ people to test the system via interviews, observa-
tions, surveys. This approach intertwined design and
evaluation as users’ feedback was iteratively used to
make design changes and improve the system. The risk
tool is nested in the cloud-based patient information
record system MMEx, which was developed by The
Centre for Software Practice in 2007 [55]. MMEx is an
e-Health platform providing electronic health records,
secure messaging, collaborative care and evidence-based
forms with clinical decision support available on mobile
platforms. MMEx has been adopted by a broad range of
primary, secondary and tertiary public healthcare ser-
vices, Aboriginal Community Controlled Health Organi-
sations and private practices in several jurisdictions of
Australia.
The risk tool is based on the NHMRC Guidelines
clinical inputs of (1) previous amputation, (2) previ-
ous foot ulcer, (3) foot deformity, (4) pulses, and (5)
peripheral neuropathy [24]. The CDSS risk output ap-
pears as the words low, intermediate or high risk and
is accompanied by the NHMRC recommendation for
each given level of risk [24]. For example, intermedi-
ate risk suggests “Review 6 months and refer for foot
protection program (includes foot care education, po-
diatry review and appropriate footwear” (Fig. 1).
The NHMRC Guidelines were transferred into an on-
line format with CDSS in two steps [24]. Initially, a
series of ‘yes/no’ flowcharts of the five clinical inputs
was created to make the decisions to decide the risk out-
put. Next, a score to determine the level of risk was
assigned with ‘No’ responses scored as zero and ‘yes’ re-
sponses scored as one point. If the five risk inputs are all
no, then the total score was zero and the risk output
was determined as ‘low risk’; if the five risk input score
equalled one then the risk output was ‘intermediate risk’;
if the risk input score was greater than one, then the risk
output was ‘high risk’. Additionally, the presence of a
current foot ulcer as a risk input was scored as greater
than one so that the output was always high risk. This
logic was the basis of the computer code in the develop-
ment of the tool. The last three elements of the risk tool
were practical risk factors that need to be considered in
Fig. 1 The risk tool
Schoen et al. Journal of Foot and Ankle Research  (2015) 8:73 Page 4 of 10
foot documentation although they had not been deter-
mined as essential elements of determining the patients’
level of risk. These were the ability to see and reach feet,
assessment of footwear and recording of diabetic foot
education provided. Their inclusion was to guide clinical
practice and prompt health professionals to undertake
recommended tasks such as providing written diabetes
education or advice on practical risks that need to be
considered and addressed.
Phased formative evaluation and iterative development
of the risk tool
Study design
Formative evaluation of the risk tool occurred in five
stages over an 8-month period and employed a mixed
methods research design consisting of semi-structured
interviews, focus group and participant observation,
online survey, expert review, comparison to NHMRC
Guidelines and clinical testing [56]. Concurrent qualita-
tive and quantitative data collection procedures were
used. Seven healthcare professionals participated in one-
to-one semi-structured interviews and observations in
Phase One. The second phase was quantitative practical
live testing in a routine clinical setting using real pa-
tients by the first author (DES) on a tablet in a private
rural podiatry practice in Western Australia. The time
taken to complete the risk tool within a clinical appoint-
ment, language, design and the accuracy of the calcu-
lated risk and recommendation were evaluated. Phase
Three involved a series of one-to-one semi-structured
interviews, observation and one focus group with local
experts and potential end users. Twenty local health
practitioners (one vascular surgeon, seven podiatrists,
four allied health, three general practitioners, three
nurses, one nurse practitioner and one Aboriginal
Health Worker) participated in one-to-one interviews.
They were given web-based access, asked to work
with the risk tool, observed during their use and then
interviewed. Supplementing this was a focus group
discussion with eight diabetes educators. The fourth
phase was a quantitative national review of the risk
tool by three podiatrists from different states of
Australia, who completed an online survey. It con-
tained four scenarios to ascertain if the calculated risk
and recommendation were accurate. The participants
responded to questions regarding the language, de-
sign, and a request for suggestions for improvement
of the risk tool. The fifth phase of the evaluation was
web-based review by four experts outside of Australia
with a publication record in diabetic foot risk stratifi-
cation systems. They appraised the system for suitability
of key criteria and suggestions for improvement.
Ethics approvals for this study were granted by the
University of Western Australia, the Western Australian
Aboriginal Health Ethics Committee and the Western
Australian Country Health Service.
Study population and setting
A total of 43 healthcare professionals participated, 26
novice and 17 experts. Seven in Phase One, one in Phase
Two, 28 in Phase Three, three in Phase Four and four in
Phase Four. The study was coordinated from Western
Australia; Phases One and Two were in rural Western
Australia, Phase Three in both rural and urban settings,
Phase Four involving participants in three Australian
states and Phase Five utilising international reviewers.
Sampling
Purposive sampling of local healthcare professionals as
potential end users of the risk tool and local, national
and international experts in diabetic risk stratification
systems participated.
Data collection
Written notes were taken during semi-structured inter-
view and observation of participants’ actions, hesitations
or when they needed prompting to complete the risk
tool and answers to questions. Live testing risk errors,
as judged by the first author based on the NHMRC
Guidelines, were recorded in MMEx [55].
Data analysis
Participants’ comments and observed actions or inaction
were thematically categorised into language, design,
workflow or risk errors. These were then translated into
concrete actions for modification by the MMEx software
development team. All suggestions were cross-checked
against NHMRC Guideline [24].
Results
Phase 1: Results of one-to-one interviews and observations
Participants were all supportive of the risk tool concept.
Positive comments were that the language was suit-
able, it was simple to use, took minimal time to find
within the electronic patient information system, and
it was easy to complete the risk tool. Participants
suggested the recommendation for the given level of
risk should be displayed at the completion of the risk
assessment information being entered.
Phase 2: Live testing
Two hundred and ninety-nine individual risk assess-
ments were completed in a real clinical setting. The risk
tool was able to be completed in less than 10 minutes
making it suitable for a clinical appointment. The CDSS
calculation was fast, taking less than 1 second to calcu-
late the risk and recommendation. Live testing revealed
risk errors due to the foot deformity score not initially
Schoen et al. Journal of Foot and Ankle Research  (2015) 8:73 Page 5 of 10
being calculated and this required further refinement by
the MMEx development team. The workflow of the risk
tool matched a standard diabetic foot assessment by
following the general medical sequencing of a clinical
examination process of history, inspection, palpation
then specialised procedures with the monofilament. This
process also encouraged good infection control proce-
dures to be followed as the history and visual inspection
could be completed without gloves on so that interaction
with the computer or tablet occurred before donning
gloves for the physical assessment. After completing
the physical tasks of the risk assessment, hands would
be cleaned appropriately and the rest of the tool com-
pleted. The self-care and education questions were
found to be difficult to deliver without leading the pa-
tient in any response/direction and, the need to refine
this part of the tool led to initiating the focus group
with diabetes educators.
Phase 3: Results of one-to-one interviews and
observations
Five language concerns were raised. Three concerns
were easily solved by correcting spelling, removing
subjective qualifiers (e.g. very/superficial) and incor-
rect definitions. The other two issues were terminology.
Participants felt “Send as HL7” was meaningless to the
user, and queried its necessity. Secondly, they suggested
the “high risk” recommendation should be “Refer to a
High Risk Foot Podiatrist.” Participants also suggested
a free text section was needed. A major workflow issue
was exposed by observation of participants. They were
unable to complete the risk tool as the “Calculate Risk”
button was at the top of the risk tool only and resulted
in participants thinking the CDSS had not worked. A
critical design flaw of the CDSS was revealed. A false
negative error occurred if the entire risk tool was not
completed. A false negative is an error in which a test
result improperly indicates no presence of a condition
(the result is negative) when in reality it is present. This
occurred during testing if one section, for example,
pulses, was not completed and results in an incorrect
risk stratification (Table 1).
Phase 3: Results of focus group with diabetes educators
Diabetes educators highlighted that the three self-care
and three education questions were ambiguous and sub-
jective. They suggested both sets of questions should be
changed from the third to the second person point of
view and directly ask patients the questions. They sug-
gested that self-care be reduced to two clear questions,
directly asking the patient if they could see and reach
their feet. The education question was recommended to
be simplified to one question only, asking the patient
what they understood. This would enable education to
be directed to any identified deficits in further foot care
education. Additionally, they suggested the clinician
should document if verbal or written, or both forms of
education were provided. Their final suggestion to im-
prove the tool was to use the features within the form
design for opportunistic education, for example, pictures
of foot deformities.
Table 1 Participant feedback from Phase three
Evaluation Participants Methodology used Feedback Changes made


























a) Risk display at bottom of form
b) Send at bottom of form
c) Boxes around each section
3. Improved Workflow
a) Changed
b) Unchanged/can be incorporated
c) Unchanged
4. Questions
a) Self-care questions too vague
b) Education questions objective
c) Education questions not specific foot knowledge
4. Questions
a) Simplified; two direct questions
b) Simplified; one direct question
c) One specific foot question
5. Suggestions
a) Opportunistic education within design
b) Free text section
5. Suggestions
a) Unchanged/can be incorporated
b) Unchanged/can be incorporated
6. Dislikes
a) Too many pens in foot deformity
b) Letters in foot deformity




VS vascular surgeon, AH allied health, NP nurse practitioner, AHW Aboriginal Health Worker, DE diabetes educator
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Phase 4: Quantitative national review
National experts confirmed the accuracy of the risk
stratification output. However, the recommendations
were incomplete and not the exact wording of the
NHMRC Guideline [24]. The language of the risk and
recommendation for a current ulcer was problematic.
They suggested the risk and recommendation be refer-
enced and a web link to the NHMRC Guidelines be in-
cluded [24]. National experts suggested the workflow
could be altered, to have the assessment of pulses and
neuropathy sections first, given their greater importance.
They also suggested having a free text section. Positive
comments are shown in Table 2.
Phase 5: International review
International reviewers suggested the current foot risk
should be more prominent and include an automatic re-
call for when the next foot assessment is due. Two ex-
perts considered the foot deformity section of the form
to be too large and to contain elements (e.g. small
muscle wasting) that were unlikely to inform risk assess-
ment. Both inclusions of vibration perception threshold
to improve sensitivity and specificity of the tool and,
adding eschar to foot deformity and rockerbottom to
Charcot foot were suggested. Additionally, they sug-
gested the tool be printable to only one page. Finally,
they also suggested using features within the risk tool
design for opportunistic education, defining the variables
or “Help” section. Positive comments received are in-
cluded in Table 2.
Discussion
Diabetic foot risk stratification with CDSS can be inte-
grated into an electronic health record with minimal im-
pact on a podiatrists’ usual workflow. A usability design
process with an early focus on end users, integrated de-
sign and early and continued user testing was important
in recognising major usability issues. Participants’ quali-
tative responses confirmed the language is suitable, gen-
erated extensive feedback for improvement and revealed
essential design flaws. Live testing and participants’
quantitative results confirmed the accuracy of the tool.
The resultant risk tool is fast, accurate, compatible with
the workflow of a diabetic foot assessment and free from
false negative errors of risk stratification based on the
2011 NHMRC Guidelines [24].
The mixed methods approach used in this study has
been advocated in the development and evaluation of
CDSS [57–63]. This approach was appropriate given the
obstacles recognized in the literature that limit the use
of CDSS. User-centered design processes can help im-
prove usability and result in more likable computer ap-
plications [54, 64]. The naturalistic design of the live
testing with real patients for field tests is suggested by
Kaplan [65] and was the approach used to validate the
Scottish Care Information – Diabetes Collaboration sys-
tem’s diabetic foot electronic decision support tool [22].
Measurement of accuracy by peer review and compari-
son to a standard guideline avoids circularity, and the
completeness of results can be supported by triangula-
tion of data from complementary methods comparing
data from semi-structured interviews, participant obser-
vation, online survey responses, NHMRC Guidelines and
clinical testing [57, 60, 62].
Other studies have shown that major usability flaws in
CDSS can be recognised by all methods regardless of the
expertise of the evaluator as they rely on observation
and are easy to perform [53, 66, 67]. Kilsdonk demon-
strated a user-centred CDSS design can overcome us-
ability problems when replacing paper-based clinical
guidelines into an online format with CDSS as we have
done in this study [64]. The Scottish Care Information –
Diabetes Collaboration system’s diabetic foot electronic
decision support tool, used similar evidence-based
guidelines to implement a diabetic foot risk stratification
tool in a central web-based database opposed to inte-
grated into an electronic health record as we have done
[22]. Our risk tool aligns with Curran’s findings of the
clinical reasoning and diagnostic procedures of novice po-
diatrists of visual cues, touch cues, questions for the pa-
tient, and then a diagnostic statement by the podiatrist
[68].
The implications of non-podiatrists using the risk tool
have been considered, as CDSS allow healthcare practi-
tioners to work at a higher level of expertise. Studies re-
port that non-podiatrists overreport the presence of foot
deformities [29, 69] and are unable to palpate reliably
pedal pulses [22, 29, 69]. This would result in a higher
risk stratification and is safe for patients with diabetes as
the NHMRC recommendation for the higher risk is for
referral to a podiatrist for second stage assessment [24].
The recent PODUS study has shown the consistent
reliability of the 10-g monofilament regardless of the
expertise of the tester, the number of sites and the
anatomical sites tested based on five different studies
and 11,522 people from three different countries [28].
Finally, the combination of clinical tests for integrated
foot risk score as we have used in this study is more
Table 2 Positive participant feedback
“…. such a simple, clear, user-friendly tool that is evidence based….”
“Also liked the pulses and neuro + and – buttons, easy to use, but also
you’ve made it slow enough so as to limit errors with too many click -
well done!”
“I think it’s wonderful and love the concept and design. ….has the
potential to be used very widely…..”
“Lovely, enjoyable and useful tool”
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sensitive than individual clinical tests for predicting
foot ulceration [24, 70, 71].
The strengths of this study were collaboration with
an experienced development team, early input from
multiple users; the mixed methods approach, and de-
velopment within a well-established patient informa-
tion record system [55]. Limitations of this study are
the small sample size, no assessment of intraobserver
reliability, and that formal usability techniques such as talk
aloud protocols or walkthroughs were not used. Further-
more, this study reports the formative evaluation of the
risk tool only. Further summative evaluation on the
complete system is warranted [62] and prospective obser-
vational studies to determine if the risk tool accurately
predicts foot ulceration in a primary healthcare setting.
Conclusion
This study illustrates that the views and experiences
of potential end users can be used effectively to de-
velop and evaluate a diabetic foot risk tool with CDSS
based on evidence-based guidelines integrated into an
electronic health record. The risk tool integrates sim-
ple assessment readily available in a clinical setting,
and should have minimal impact on experienced
healthcare professionals’ usual workflow and reflects
current Australian guidelines [24]. It also structures
foot examination for those who are less proficient in
diabetic foot assessment and will ensure that identified
predictors of risk for foot ulcers are referred in a more
timely way for definitive assessment and management.
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